Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE KREHER-PEYROUX : revenue, balance sheet and financial ratios

PHARMACIE KREHER-PEYROUX is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTEREAU-FAULT-YONNE (77130), this company of category PME shows in 2025 a net income positive of 76 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE KREHER-PEYROUX (SIREN 524352119)
Indicador 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Ingresos N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Resultado neto 75 978 € 47 388 € 111 286 € 354 759 € -362 463 € 50 000 € 52 172 € 30 382 € 95 543 € 36 860 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Margen neto N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Ingresos y cuenta de resultados

In 2025, PHARMACIE KREHER-PEYROUX generates positive net income of 76 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 37 k€ -> 76 k€.

Resultado neto (2025) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

75 978 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.

Ratio de endeudamiento (2025) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

115.068%

Autonomía financiera (2025) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

39.785%

Ratio de obsolescencia (2025) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

35.3%

Evolución de indicadores de solvencia
PHARMACIE KREHER-PEYROUX

Positionnement sectoriel

Debt ratio
115.07 2025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average +7 pts durante 3 años

In 2025, the debt ratio of PHARMACIE KREHER-PEYROUX (115.07) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
39.78% 2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Average

In 2025, the financial autonomy of PHARMACIE KREHER-PEYROUX (39.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 117.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2025) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

117.015

Evolución de indicadores de liquidez
PHARMACIE KREHER-PEYROUX

Positionnement sectoriel

Liquidity ratio
117.02 2025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Watch -18 pts durante 3 años

In 2025, the liquidity ratio of PHARMACIE KREHER-PEYROUX (117.02) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positionnement de PHARMACIE KREHER-PEYROUX dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE KREHER-PEYROUX is estimated at 1 206 919 € (range 819 021€ - 1 893 822€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
819k€ 1206k€ 1893k€
1 206 919 € Range: 819 021€ - 1 893 822€
NAF 5 année 2025

Valuation method used

Net Income Multiple
75 978 € × 15.9x = 1 206 920 €
Range: 819 021€ - 1 893 823€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE KREHER-PEYROUX with other companies in the same sector:

Frequently asked questions about PHARMACIE KREHER-PEYROUX

What is the revenue of PHARMACIE KREHER-PEYROUX ?

The revenue of PHARMACIE KREHER-PEYROUX is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE KREHER-PEYROUX profitable?

Yes, PHARMACIE KREHER-PEYROUX generated a net profit of 76 k€ in 2025.

Where is the headquarters of PHARMACIE KREHER-PEYROUX ?

The headquarters of PHARMACIE KREHER-PEYROUX is located in MONTEREAU-FAULT-YONNE (77130), in the department Seine-et-Marne.

Where to find the tax return of PHARMACIE KREHER-PEYROUX ?

The tax return of PHARMACIE KREHER-PEYROUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE KREHER-PEYROUX operate?

PHARMACIE KREHER-PEYROUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.